ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Odonate Therapeutics Inc

Odonate Therapeutics Inc (ODT)

1.12
0.00
( 0.00% )
更新日時: 09:00:00

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
1.12
買値
1.11
売値
1.16
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
1.12
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
14,626,000
配当利回り
-
PER
2.24
1 株当たり利益 (EPS)
0.5
歳入
-
純利益
7.33M

Odonate Therapeutics Inc について

Odonate Therapeutics Inc is a Shell company. Odonate Therapeutics Inc is a Shell company.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-

ODT 最新ニュース

Odonate Announces Expected Delisting of Its Stock

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that Nasdaq believes that...

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in...

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021. As of September 30, 2021, Odonate had $95.0 million in cash...

SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma...

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021. In March 2021, Odonate announced the discontinuation of development...

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021. Odonate recently announced the discontinuation of development of tesetaxel...

Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel

Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clinical data package...

Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today...

Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 S...

CONTESSA Achieved Primary Endpoint – Tesetaxel Plus a Reduced Dose of Capecitabine Significantly Improved Progression-free Survival (PFS) Versus the Approved Dose of Capecitabine Alone (Hazard...

Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast...

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ODT - Frequently Asked Questions (FAQ)

What is the current Odonate Therapeutics share price?
The current share price of Odonate Therapeutics is US$ 1.12
How many Odonate Therapeutics shares are in issue?
Odonate Therapeutics has 14,626,000 shares in issue
What is the market cap of Odonate Therapeutics?
The market capitalisation of Odonate Therapeutics is USD 16.38M
What is the 1 year trading range for Odonate Therapeutics share price?
Odonate Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Odonate Therapeutics?
The price to earnings ratio of Odonate Therapeutics is 2.24
What is the reporting currency for Odonate Therapeutics?
Odonate Therapeutics reports financial results in USD
What is the latest annual profit for Odonate Therapeutics?
The latest annual profit of Odonate Therapeutics is USD 7.33M
What is the registered address of Odonate Therapeutics?
The registered address for Odonate Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Odonate Therapeutics website address?
The website address for Odonate Therapeutics is www.odonate.com
Which industry sector does Odonate Therapeutics operate in?
Odonate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GITSGlobal Interactive Technologies Inc
US$ 2.05
(2,006.89%)
22.34k
YIBOPlanet Image International Ltd
US$ 9.99
(364.65%)
5.7M
JGAurora Mobile Ltd
US$ 14.06
(133.86%)
21.51M
AKROAkero Therapeutics Inc
US$ 53.665
(104.98%)
8.89M
HWHHWH International Inc
US$ 0.5298
(84.15%)
117.3M
ALLKAllakos Inc
US$ 0.26345
(-78.23%)
19.67M
VERUVeru Inc
US$ 0.6756
(-44.17%)
24.64M
NXUNXU Inc
US$ 0.35005
(-43.17%)
3.29M
ELABPMGC Holdings Inc
US$ 2.0103
(-35.15%)
2.61M
NBISNebius Group NV
US$ 29.33
(-29.65%)
17.71M
NVDANVIDIA Corporation
US$ 124.59
(-12.64%)
231.46M
ONCOOnconetix Inc
US$ 0.7316
(52.42%)
154.26M
HOLOMicroCloud Hologram Inc
US$ 1.86
(20.00%)
143.77M
HWHHWH International Inc
US$ 0.532
(84.91%)
117.42M
RIMEAlgorhythm Holdings Inc
US$ 0.0347
(-8.20%)
59.23M

最近閲覧した銘柄

Delayed Upgrade Clock